Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan

Regorafenib (REG) and trifluridine/tipiracil (FTD/TPI) showed survival benefits in metastatic colorectal cancer patients previously treated with standard chemotherapies; therefore, we compared the efficacy and safety of these two treatments. Patients with metastatic colorectal cancer treated with RE...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Misato, Kotaka, Masahito, Ogata, Takatsugu, Hatachi, Yukimasa, Yasui, Hisateru, Kato, Takeshi, Tsuji, Akihito, Satake, Hironaga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292354/
https://www.ncbi.nlm.nih.gov/pubmed/32530932
http://dx.doi.org/10.1371/journal.pone.0234314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292354/
https://www.ncbi.nlm.nih.gov/pubmed/32530932
http://dx.doi.org/10.1371/journal.pone.0234314

Ejemplares similares